Clinical Trials Results - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -5 of 5 Show results per page	View Search Criteria \| Help With Results


Sort By:	Version:	Format:

First Published: 9/6/2007


1.		Phase II Study of Photodynamic Therapy Using HPPH in Patients With Advanced Obstructing Endobronchial Non-Small Cell Lung Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				18 and over				NCI				RPCI-I-98707 I98707, NCT00528775

Last Modified: 5/7/2007 First Published: 5/1/2007


2.		Phase I Pilot Study of Photodynamic Therapy Comprising HPPH in Patients Undergoing Surgery For Primary or Recurrent Squamous Cell Cancer of the Head and Neck

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Active				18 and over				NCI				RPCI-I-74606 NCT00470496

First Published: 8/30/2007


3.		Phase I Study of Photodynamic Therapy Using HPPH in Patients With In Situ or Microinvasive Bronchogenic Non-Small Cell Carcinoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Active				18 and over				NCI				RPCI-I-05903 I 05903, NCT00526461

First Published: 4/29/2008


4.		Phase I Study of Photodynamic Therapy Comprising HPPH in Patients With Recurrent Dysplasia, Carcinoma in Situ, or Stage I Squamous Cell Carcinoma of the Oral Cavity

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Active				18 and over				NCI				RPCI-I-109307 I 109307, NCT00670397

Last Modified: 5/27/2008 First Published: 5/7/2008


5.		Phase I Study of Photodynamic Therapy Using HPPH in Patients With Dysplasia, Squamous Cell Carcinoma in Situ, or T1 Squamous Cell Carcinoma of the Larynx

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Active				18 and over				NCI				RPCI-I-119207 I 119207, NCT00675233

Select All on One Page

| | | | | | | |

A Service of the National Cancer Institute